Targeted proteomics in extracellular vesicles identifies biomarkers predictive for therapeutic response in sarcoidosis
Background ∼30% of patients with sarcoidosis, a systemic granulomatous disease of unknown cause, need treatment to alleviate symptoms or prevent organ damage. Prednisone and methotrexate (MTX) are the most commonly used drugs; however, success of treatment varies from patient to patient. In this stu...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-03-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/11/2/00672-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|